• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    UL Solutions Inc. Reports Strong First Quarter 2026 Results

    5/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email

    First Quarter 20261

    • Strong revenue growth of 7.5% to $758 million, including 5.7% organic revenue growth
    • Net income of $97 million increased 36.6%, Adjusted Net Income of $107 million increased 33.8%. Net income margin of 12.8% increased 270 basis points
    • Diluted earnings per share of $0.45 increased 36.4%, Adjusted Diluted Earnings Per Share of $0.50 increased 35.1%
    • Adjusted EBITDA of $197 million increased 22.4%, Adjusted EBITDA margin of 26.0% expanded 320 basis points
    • Active portfolio management to enhance strategic focus and fund growth
    • Strengthens full-year Adjusted EBITDA margin outlook

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today reported results for the first quarter ended March 31, 2026.

    "I'm thrilled to report that our first quarter results extended our track record of strong performance including revenue growth, solid cash flow generation and impressive margin expansion," said President and CEO Jennifer Scanlon. "Our approach to align strategically with global megatrends continues to deliver shareholder value, and our strong balance sheet provides ample capacity to take advantage of additional opportunities for growth and relevance. We're excited and energized about the remainder of 2026."

    "Our financial performance reflects the quality of our revenue growth and our ongoing commitment to optimize our cost structure," said Ryan Robinson, Chief Financial Officer. "Organic revenue growth of 5.7% exceeded our expectations, driven by momentum in ongoing certification services and strong demand in certification testing. Adjusted EBITDA margin expanded 320 basis points to 26.0%, supported by disciplined headcount and expense management and resulting in continued solid cash generation. Active portfolio management remains an important focus, including our agreement to acquire Eurofins' E&E business, which we expect to enhance our testing, inspection and certification capabilities and reinforces M&A as an important driver of our long-term value creation. With this strong start to the year, we are pleased to strengthen our full-year 2026 Adjusted EBITDA margin outlook."

    First Quarter 2026 Financial Results

    Revenue of $758 million compared to $705 million in the first quarter of 2025, an increase of 7.5%. Organic revenue growth of 5.7%, led by the Industrial segment.

    Net income of $97 million compared to $71 million in the first quarter of 2025, an increase of 36.6%. Net income margin of 12.8% compared to 10.1% in the first quarter of 2025, an increase of 270 basis points. The margin increase was driven by higher revenue and operating leverage.

    Adjusted Net Income of $107 million compared to $80 million in the first quarter of 2025, an increase of 33.8%. Adjusted Net Income margin of 14.1% compared to 11.3% in the first quarter of 2025, an increase of 280 basis points.

    Diluted earnings per share of $0.45 compared to $0.33 in the first quarter of 2025, an increase of $0.12. Adjusted Diluted Earnings Per Share of $0.50 compared to $0.37 in the first quarter of 2025, an increase of $0.13.

    Adjusted EBITDA of $197 million compared to $161 million in the first quarter of 2025, an increase of 22.4%. Adjusted EBITDA margin of 26.0% compared to 22.8% in the first quarter of 2025, an increase of 320 basis points. The margin expansion resulted from higher revenue and operating leverage, led by the Industrial and Consumer segments.

    1This press release includes references to non-GAAP financial measures. Please refer to "Non-GAAP Financial Measures" later in this release for the definitions of each non-GAAP financial measure presented, as well as reconciliations of these measures to their most directly comparable GAAP measures. All comparisons are to first quarter 2025 unless otherwise noted.

     Liquidity and Capital Resources

    For the three months ended March 31, 2026, the Company generated $219 million of net cash provided by operating activities, an increase from $154 million for the same period in 2025. Net cash provided by operating activities for the three months ended March 31, 2026 was a result of improved business performance and timing of certain working capital items.

    During the first quarter, the Company continued to make strategic capital investments intended to meet increased demand and drive greater productivity. Capital expenditures were $69 million for the three months ended March 31, 2026, compared to $51 million for the same period in 2025. Free Cash Flow for the three months ended March 31, 2026 was $150 million, compared to $103 million for the same period in 2025.

    The Company paid a dividend of $0.145 per share, or $29 million, during the three months ended March 31, 2026.

    As of March 31, 2026, total debt was $360 million, prior to unamortized debt issuance costs, a decrease from December 31, 2025 due to $134 million of net repayments on the Company's revolving credit facility.

    The Company ended the quarter with cash and cash-equivalents of $258 million, compared to $295 million of cash and cash-equivalents as of December 31, 2025.

    Portfolio Management Activities

    On April 1, 2026, the Company closed on the previously announced sale of its Employee Health and Safety software business that was accounted for in the Company's Risk & Compliance Software segment, for a preliminary purchase price of approximately $202 million in cash consideration, subject to customary post-closing adjustments.

    On April 13, 2026, the Company announced it had entered into a definitive agreement to acquire the electrical and electronics (E&E) business of Eurofins Scientific SE ("Eurofins"), valued at an enterprise value of approximately €575 million. The acquisition is expected to extend the Company's capabilities in key geographies including EMEA and Asia-Pacific and help drive continued growth in the Consumer segment by bringing together a global infrastructure of complementary electrical testing and certification services to meet customer needs. The Company expects to fund the transaction through a combination of its existing cash and revolving credit facility. Aligned with the Company's strategy of focusing its portfolio on TIC and Risk & Compliance software capabilities, approximately 45% of the purchase price is anticipated to be funded through the Company's portfolio management activities. The transaction, subject to regulatory approvals and other customary closing conditions, is expected to close in the fourth quarter of 2026.

    On April 27, 2026, the Company entered into a definitive agreement to sell its approximately 28% shareholding of DQS Holding GmbH ("DQS"), a global management system assessment company headquartered in Germany. The Company expects to receive approximately €105 million in cash consideration, subject to customary post-closing adjustments, a portion of which will be held in escrow to cover certain indemnification obligations under the share purchase and transfer agreement. The Company accounts for DQS using the equity method and DQS financial results are not consolidated within the Company's financial statements. The sale is expected to be completed in the second half of 2026, subject to the satisfaction of customary closing conditions, including applicable regulatory approvals.

    Full-Year 2026 Outlook

    The Company's 2026 outlook includes:

    • Mid-single digit constant currency organic revenue growth
      • Inclusive of approximately 1% revenue reduction from the previously announced expense reduction initiative (the "Restructuring Plan")
    • Adjusted EBITDA margin improvement to approximately 27.0%
    • Effective tax rate of approximately 26%
    • Capital expenditures between 7% and 8% of revenue
    • Continuing to pursue acquisitions and portfolio refinements

    The Company's 2026 outlook is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurance that the Company will achieve the results expressed by this outlook, which may be impacted by, among other things, implementation of the Restructuring Plan. In addition, the geopolitical environment and attendant increased levels of uncertainty have caused, and may continue to cause, the Company's customers to modify, delay or cancel plans to purchase services. Accordingly, ongoing uncertainty related to the current geopolitical environment and the associated unpredictability of the macroeconomic environment could have an adverse impact on various aspects of the Company's business in the future, including its results of operations and financial condition. The Company is unable at this time to reasonably determine any future negative impacts from reduced or delayed customer testing or product development as a result of uncertainty that may result from the current geopolitical environment.

    The Company does not provide guidance for net income margin, the most directly comparable GAAP measure to Adjusted EBITDA margin, and similarly cannot provide a reconciliation between its forecasted Adjusted EBITDA margin and net income margin without unreasonable effort due to the unavailability of reliable estimates for certain components of net income and the respective reconciliations. These forecasted items are not within the Company's control, may vary greatly between periods and could significantly impact future financial results.

    Conference Call and Webcast

    UL Solutions will host a conference call today at 8:30 am ET to discuss the Company's financial results. The live webcast of the conference call and accompanying presentation materials can be accessed through the UL Solutions Investor Relations website at ir.ul.com. For those unable to access the webcast, the conference call can be accessed by dialing 1-877-407-0792 (domestic) or 1-201-689-8263 (international). An archive of the webcast will be available on the Company's website for 30 days.

    About UL Solutions

    A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, advisory offerings and software solutions, that support our customers' product innovation and business growth. The UL Mark serves as a recognized symbol of trust in our customers' products and reflects an unwavering commitment to advancing our safety mission. We help our customers innovate, launch new products and services, navigate global markets and complex supply chains, and grow sustainably and responsibly into the future. Our science is your advantage.

    Additional Information and Where to Find It

    Investors and others should note that UL Solutions intends to routinely announce material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the UL Solutions Investor Relations website. We also intend to use certain social media channels as a means of disclosing information about us and our products to consumers, our customers, investors and the public on our X account (@UL_Solutions) and our LinkedIn account (@ULSolutions). The information posted on social media channels is not incorporated by reference in this press release or in any other report or document we file with the SEC. While not all of the information that the Company posts to the UL Solutions Investor Relations website or to social media accounts is of a material nature, some information could be deemed to be material, including earnings and investor presentations. Accordingly, the Company encourages investors, the media, and others interested in UL Solutions to review the information shared on our Investor Relations website at ir.ul.com and to regularly follow our social media accounts. Users can automatically receive email alerts and information about the Company by subscribing to "Investor Email Alerts" at the bottom of the UL Solutions Investor Relations website at ir.ul.com.

    Forward-Looking Statements

    This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. These include statements regarding management's objectives for future operations and the Company's plans, business strategy, outlook and future results of operations and financial position, including without limitation, the statements under the heading "Full-Year 2026 Outlook," statements regarding the Company's expected growth, future capital expenditures and the Restructuring Plan, including the Company's estimates of the charges and expenditures in connection therewith and the timing thereof and the Company's estimates of the benefits of such Restructuring Plan, and statements regarding the Company's acquisitions, divestitures and other strategic transactions, including expected timing, closing, proceeds, financing, synergies and financial impact. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "would," "likely," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "continues," "outlook" and variations of these terms and similar expressions, or the negative of these terms or similar expressions (although not all forward-looking statements may contain such words). The Company cautions you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

    There are or will be important factors that could cause the Company's actual results to differ materially from those expressed or implied by the forward-looking statements made in this press release, including, but not limited to, the following: any failure on the Company's part to protect and maintain its brand and reputation, or the impact on its brand or reputation of third-party events or actions outside of its control; risks associated with the Company's information technology and software, including those relating to any future data breach or other cybersecurity incident; the potential disruption of the industries in which the Company operates by technological advances in artificial intelligence; the Company's ability to innovate, adapt to changing customer needs and successfully introduce new products and services in response to changes in the Company's industries and technological advances; the Company's ability to compete in its industries and the effects of increased competition from its competitors; risks associated with conducting business outside the United States, including those relating to fluctuations in foreign currency exchange rates; the imposition of tariffs and enhanced trade, import or export restrictions or changes in U.S. trade policy or similar government actions; and global, regional or political instability and geopolitical tensions; risks related to sustainability; risks associated with the Company's operations in China, which subject the Company and UL-CCIC Company Limited, the Company's joint venture with the China Certification & Inspection (Group) Co., Ltd. ("CCIC"), to China's complex and rapidly evolving laws, which may be interpreted, applied or enforced inconsistently or in ways inconsistent with its current operations, as well as risks associated with the fact that the Chinese government has the power to exercise significant oversight and discretion over, and intervene in and influence, its business operations in China; the relationship between the United States and China and between the Company and CCIC, as well as changes in U.S. and Chinese regulations affecting the Company's business operations in China; any failure on the Company's part to attract, hire or retain its key employees, including its senior leadership and its skilled and trained engineering, technical and professional personnel; the level of the Company's customers' satisfaction and any failure on its part to properly and timely perform its services, meet its contractual obligations or fulfil its customers' needs; changes to the relevant regulatory frameworks or private sector requirements, including any requirement that the Company accept third-party test results or certifications of components, end products, processes or systems or any changes that result in a reduction in required inspections, tests or certifications or harmonized international or cross-industry benchmarks and standards; the Company's ability to adequately maintain, protect and enhance its intellectual property, including its registered UL-in-a-circle certification mark and other certification marks; the Company's ability to implement its growth strategies and initiatives successfully; the Company's reliance on third parties, including subcontractors and outside laboratories; the Company's ability to obtain and maintain the requisite licenses, approvals, accreditations and delegations of authority necessary to conduct its business; the outcomes of current and future legal proceedings; the Company's level of indebtedness and future cash needs; failure to generate sufficient cash to service the Company's indebtedness; a change in the assumptions the Company uses to value its goodwill or intangible assets, or the impairment of its goodwill or intangible assets; the Company's ability to generate sufficient cash to service its indebtedness and invest in the ongoing needs of its business; the increased expenses and responsibilities associated with being a public company; the significant influence that ULSE Inc., its parent and controlling stockholder, has over the Company, including pursuant to its rights under the Company's amended and restated certificate of incorporation and the Stockholder Agreement, dated as of April 2, 2024, by and between the Company and ULSE Inc.; natural disasters and other catastrophic events, including pandemics and the rapid spread of contagious illnesses; changes in tax laws in jurisdictions in which the Company operates or adverse outcomes resulting from examination of the Company's or its affiliates' tax returns; risks that the Company may be unable to implement the Restructuring Plan on the anticipated timing, that local law and consultation requirements, including for potential position eliminations, extends the restructuring process further in certain countries or causes the actual charges and expenditures that the Company incurs in connection with the Restructuring Plan, and the timing thereof, to differ materially from estimates, that the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Restructuring Plan and that the Company may not be able to realize the anticipated benefits of the Restructuring Plan; the occurrence of any event, change, or other circumstance that could give rise to the termination of the E&E Transaction and the payment of a break fee; the possibility that one or more closing conditions to the E&E Transaction, including the receipt of certain regulatory approvals, may not be satisfied or waived, in a timely manner or at all, including the risk that a governmental entity may prohibit, delay, or refuse to grant approval for the consummation of the E&E Transaction, or may require conditions, limitations, or restrictions in connection with such approvals; the risk that the E&E Transaction may not be completed within the expected timeframe, or at all; unexpected costs, charges or expenses resulting from the E&E Transaction; uncertainty regarding the expected financial performance following completion of the E&E Transaction; the Company's ability to achieve its short-term and long-term operating targets following completion of the E&E Transaction; the effects that the announcement or pendency of the E&E Transaction may have on the Company; the acquired business' and the Company's respective businesses and ability to retain and hire key personnel and maintain relationships with customers, suppliers and others with whom the acquired business or the Company do business; the effects that termination of the E&E Transaction may have on the Company or its business; failure to successfully complete the E&E Transaction; legal proceedings that may be instituted related to the E&E Transaction; the Company's ability or failure to successfully integrate the acquired business with existing operations; and the Company's ability to realize anticipated synergies or obtain the results anticipated; and other factors discussed in the Company's filings with the Securities and Exchange Commission (the "SEC"), including those set forth under "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and under "Risk Factors" in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2025, as well as other factors described from time to time in the Company's filings with the SEC.

    If one or more events related to these or other risks or uncertainties materialize, or if the Company's underlying assumptions prove to be incorrect, actual results may differ materially from what the Company anticipates. Many of the important factors that will determine these results are beyond the Company's ability to control or predict. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, the Company does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. If the Company updates one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect to those or other forward-looking statements. New factors emerge from time to time, and it is not possible for the Company to predict which will arise. In addition, the Company cannot assess the impact of each factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements attributable to the Company, or others acting on the Company's behalf, are expressly qualified in their entirety by the cautionary statements above.

    Non-GAAP Financial Measures

    In addition to financial measures determined in accordance with accounting principles generally accepted in the United States of America ("GAAP"), this press release includes supplemental non-GAAP financial measures, including the presentation of Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Net Income margin, Adjusted Diluted Earnings Per Share, Free Cash Flow and Free Cash Flow margin. Management uses non-GAAP financial measures in addition to GAAP measures to understand and compare operating results across periods and for forecasting and other purposes. Management believes these non-GAAP financial measures provide useful information to investors and reflect results in a manner that enables, in some instances, more meaningful analysis of trends and facilitates comparison of results across periods. These measures are not financial measures calculated in accordance with GAAP and should not be considered as a substitute for net income, operating income, diluted earnings per share, net cash provided by operating activities or any other measure calculated in accordance with GAAP, and may not be comparable to similarly titled measures reported by other companies due to potential differences between the companies in calculations.

    The Company uses Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted Net Income margin and Adjusted Diluted Earnings Per Share to measure the operational strength and performance of its business and believes these measures provide additional information to investors about certain non-cash items and unusual items that the Company does not expect to continue at the same level in the future. Further, management believes these non-GAAP financial measures provide a meaningful measure of business performance. The Company uses Free Cash Flow and Free Cash Flow margin as additional liquidity measures and believes they provide useful information to investors about the cash generated from the Company's core operations that may be available to repay debt, make other investments and return cash to stockholders.

    There are material limitations to using these non-GAAP financial measures. Adjusted EBITDA does not take into account certain significant items, including depreciation and amortization, interest expense, other expense, net, income tax expense, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income, as applicable. Adjusted Net Income and Adjusted Diluted Earnings Per Share do not take into account certain significant items, including other expense, net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income and diluted earnings per share, as applicable. Free Cash Flow adjusts for cash items that are ultimately within management's discretion to direct and therefore may imply that there is less or more cash that is available than the most comparable GAAP measure. Free Cash Flow is not intended to represent residual cash flow for discretionary expenditures since debt repayment requirements and other non-discretionary expenditures are not deducted. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering these non-GAAP financial measures in conjunction with net income, operating income, diluted earnings per share and net cash provided by operating activities as calculated in accordance with GAAP.

    See additional information below for definitions of these non-GAAP financial measures, and reconciliations to their most directly comparable GAAP measures.

    UL Solutions Inc.

    Condensed Consolidated Statements of Operations

    (Unaudited)

     

    Three Months Ended

    March 31,

    (in millions, except per share data)

     

    2026

     

     

     

    2025

     

    Revenue

    $

    758

     

     

    $

    705

     

    Cost of revenue

     

    377

     

     

     

    365

     

    Selling, general and administrative expenses

     

    243

     

     

     

    232

     

    Restructuring

     

    —

     

     

     

    (1

    )

    Operating income

     

    138

     

     

     

    109

     

    Interest expense

     

    (8

    )

     

     

    (12

    )

    Other expense, net

     

    (1

    )

     

     

    (3

    )

    Income before income taxes

     

    129

     

     

     

    94

     

    Income tax expense

     

    32

     

     

     

    23

     

    Net income

     

    97

     

     

     

    71

     

    Less: net income attributable to non-controlling interests

     

    5

     

     

     

    4

     

    Net income attributable to stockholders of UL Solutions

    $

    92

     

     

    $

    67

     

     

     

     

     

    Earnings per common share:

     

     

     

    Basic

    $

    0.46

     

     

    $

    0.34

     

    Diluted

    $

    0.45

     

     

    $

    0.33

     

     

     

     

     

    Weighted average common shares outstanding:

     

     

     

    Basic

     

    201

     

     

     

    200

     

    Diluted

     

    204

     

     

     

    203

     

    UL Solutions Inc.

    Condensed Consolidated Balance Sheets

    (Unaudited)

    (in millions)

    March 31, 2026

     

    December 31, 2025

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    258

     

    $

    295

    Accounts receivable, net

     

    497

     

     

    422

    Contract assets, net

     

    222

     

     

    204

    Other current assets

     

    70

     

     

    79

    Total current assets

     

    1,047

     

     

    1,000

    Property, plant and equipment, net

     

    711

     

     

    699

    Goodwill

     

    643

     

     

    656

    Intangible assets, net

     

    44

     

     

    48

    Operating lease right-of-use assets

     

    173

     

     

    179

    Deferred income taxes

     

    92

     

     

    94

    Capitalized software, net

     

    93

     

     

    105

    Other assets

     

    152

     

     

    140

    Total Assets

    $

    2,955

     

    $

    2,921

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

     

    168

     

     

    183

    Accrued compensation and benefits

     

    188

     

     

    282

    Operating lease liabilities - current

     

    41

     

     

    43

    Contract liabilities

     

    410

     

     

    173

    Other current liabilities

     

    92

     

     

    79

    Total current liabilities

     

    899

     

     

    760

    Long-term debt

     

    357

     

     

    491

    Pension and postretirement benefit plans

     

    125

     

     

    134

    Operating lease liabilities

     

    141

     

     

    149

    Other liabilities

     

    97

     

     

    93

    Total Liabilities

     

    1,619

     

     

    1,627

    Total Stockholders' Equity

     

    1,336

     

     

    1,294

    Total Liabilities and Stockholders' Equity

    $

    2,955

     

    $

    2,921

    UL Solutions Inc.

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)

    Three Months Ended March 31,

    (in millions)

     

    2026

     

     

     

    2025

     

    Operating activities

     

     

     

    Net cash flows provided by operating activities

    $

    219

     

     

    $

    154

     

     

     

     

     

    Investing activities

     

     

     

    Capital expenditures

     

    (69

    )

     

     

    (51

    )

    Sales of investments, net

     

    8

     

     

     

    —

     

    Other investing activities, net

     

    —

     

     

     

    1

     

    Net cash flows used in investing activities

     

    (61

    )

     

     

    (50

    )

     

     

     

     

    Financing activities

     

     

     

    Repayments of long-term debt, net

     

    (134

    )

     

     

    (90

    )

    Dividends to stockholders of UL Solutions

     

    (29

    )

     

     

    (26

    )

    Dividends to non-controlling interest

     

    (20

    )

     

     

    (17

    )

    Employee taxes paid on settlement of stock-based compensation

     

    (9

    )

     

     

    —

     

    Other financing activities, net

     

    (2

    )

     

     

    (2

    )

    Net cash flows used in financing activities

     

    (194

    )

     

     

    (135

    )

     

     

     

     

    Effect of exchange rate changes on cash and cash equivalents

     

    (1

    )

     

     

    —

     

     

     

     

     

    Net decrease in cash and cash equivalents

     

    (37

    )

     

     

    (31

    )

     

     

     

     

    Cash and cash equivalents

     

     

     

    Beginning of period

     

    295

     

     

     

    298

     

    End of period

    $

    258

     

     

    $

    267

     

    UL Solutions Inc.

    Supplemental Financial Information

    (Unaudited)

    Revenue by Major Service Category

    Three Months Ended March 31,

    (in millions)

     

    2026

     

     

    2025

    Certification Testing

    $

    211

     

    $

    189

    Ongoing Certification Services

     

    265

     

     

    245

    Non-certification Testing and Other Services

     

    209

     

     

    203

    Software

     

    73

     

     

    68

    Total

    $

    758

     

    $

    705

    Revenue by Segment

    Three Months Ended March 31,

     

     

     

     

    (in millions)

     

    2026

     

     

    2025

     

    Change

     

    % Change

    Industrial

    $

    375

     

    $

    340

     

    $

    35

     

    10.3

    %

    Consumer

     

    318

     

     

    304

     

     

    14

     

    4.6

    %

    Risk & Compliance Software

     

    65

     

     

    61

     

     

    4

     

    6.6

    %

    Total

    $

    758

     

    $

    705

     

    $

    53

     

    7.5

    %

    Revenue Change Components

    Three Months Ended March 31, 2026

     

     

     

     

    (in millions)

    Organic1

     

    FX2

     

    Total

     

    Organic % Change

     

    Total % Change

    Revenue change

     

     

     

     

     

     

     

     

     

    Industrial

    $

    28

     

    $

    7

     

    $

    35

     

    8.2

    %

     

    10.3

    %

    Consumer

     

    9

     

     

    5

     

     

    14

     

    3.0

    %

     

    4.6

    %

    Risk & Compliance Software

     

    3

     

     

    1

     

     

    4

     

    4.9

    %

     

    6.6

    %

    Total

    $

    40

     

    $

    13

     

    $

    53

     

    5.7

    %

     

    7.5

    %

    _________

    1.

    Organic reflects revenue change in a given period excluding Acquisition / Divestiture and FX in that same period, expressed in dollars or as a percentage of revenue in the prior period.

     

     

    2.

    FX reflects the impact that foreign currency exchange rates have on revenue in a given period, expressed in dollars or as a percentage of revenue in the prior period. The Company uses constant currency to calculate the FX impact on revenue in a given period by translating current period revenues at prior period exchange rates, expressed as a percentage of revenue in the prior period.

    The table below reconciles net income to Adjusted EBITDA.

     

    Three Months Ended March 31,

    (in millions, unless otherwise stated)

     

    2026

     

     

     

    2025

     

    Net income

    $

    97

     

     

    $

    71

     

    Depreciation and amortization expense

     

    47

     

     

     

    45

     

    Interest expense

     

    8

     

     

     

    12

     

    Other expense, net

     

    1

     

     

     

    3

     

    Income tax expense

     

    32

     

     

     

    23

     

    Stock-based compensation

     

    12

     

     

     

    8

     

    Restructuring

     

    —

     

     

     

    (1

    )

    Adjusted EBITDA1

    $

    197

     

     

    $

    161

     

    Revenue

    $

    758

     

     

    $

    705

     

    Net income margin

     

    12.8

    %

     

     

    10.1

    %

    Adjusted EBITDA margin2

     

    26.0

    %

     

     

    22.8

    %

    __________

    1.

    The Company defines Adjusted EBITDA as net income adjusted for depreciation and amortization expense, interest expense, other expense, net, income tax expense, as well as stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses, as applicable. The Company believes that the presentation of Adjusted EBITDA provides additional information to investors about certain non-cash items and unusual items that are not expected to continue at the same level in the future. Further, the Company believes Adjusted EBITDA provides a meaningful measure of business performance. There are material limitations to using Adjusted EBITDA. Adjusted EBITDA does not take into account certain significant items, including depreciation and amortization, interest expense, other expense, net, income tax expense, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income, as applicable. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Adjusted EBITDA in conjunction with net income as calculated in accordance with GAAP.

     

     

    2.

    Adjusted EBITDA margin is calculated as Adjusted EBITDA as a percentage of revenue.

    The table below reconciles segment operating income to segment Adjusted EBITDA.

     

    Three Months Ended March 31,

    (in millions, unless otherwise stated)

     

    2026

     

     

     

    2025

     

    Industrial

     

     

     

    Segment operating income

    $

    101

     

     

    $

    83

     

    Depreciation and amortization expense

     

    16

     

     

     

    16

     

    Stock-based compensation

     

    5

     

     

     

    3

     

    Restructuring

     

    1

     

     

     

    —

     

    Adjusted EBITDA1

    $

    123

     

     

    $

    102

     

    Revenue

    $

    375

     

     

    $

    340

     

    Operating income margin

     

    26.9

    %

     

     

    24.4

    %

    Adjusted EBITDA margin2

     

    32.8

    %

     

     

    30.0

    %

     

     

     

     

    Consumer

     

     

     

    Segment operating income

    $

    30

     

     

    $

    22

     

    Depreciation and amortization expense

     

    21

     

     

     

    19

     

    Stock-based compensation

     

    5

     

     

     

    4

     

    Restructuring

     

    (1

    )

     

     

    (1

    )

    Adjusted EBITDA1

    $

    55

     

     

    $

    44

     

    Revenue

    $

    318

     

     

    $

    304

     

    Operating income margin

     

    9.4

    %

     

     

    7.2

    %

    Adjusted EBITDA margin2

     

    17.3

    %

     

     

    14.5

    %

     

     

     

     

    Risk & Compliance Software

     

     

     

    Segment operating income

    $

    7

     

     

    $

    4

     

    Depreciation and amortization expense

     

    10

     

     

     

    10

     

    Stock-based compensation

     

    2

     

     

     

    1

     

    Adjusted EBITDA1

    $

    19

     

     

    $

    15

     

    Revenue

    $

    65

     

     

    $

    61

     

    Operating income margin

     

    10.8

    %

     

     

    6.6

    %

    Adjusted EBITDA margin2

     

    29.2

    %

     

     

    24.6

    %

     

     

     

     

    Adjusted EBITDA1

    $

    197

     

     

    $

    161

     

    __________

    1. See definition on previous page.

    2. See definition on previous page.

    The table below reconciles net income to Adjusted Net Income.

     

    Three Months Ended March 31,

    (in millions, unless otherwise stated)

     

    2026

     

     

     

    2025

     

    Net income

    $

    97

     

     

    $

    71

     

    Other expense, net

     

    1

     

     

     

    3

     

    Stock-based compensation

     

    12

     

     

     

    8

     

    Restructuring

     

    —

     

     

     

    (1

    )

    Tax effect of adjustments3

     

    (3

    )

     

     

    (1

    )

    Adjusted Net Income1

    $

    107

     

     

    $

    80

     

    Revenue

    $

    758

     

     

    $

    705

     

    Net income margin

     

    12.8

    %

     

     

    10.1

    %

    Adjusted Net Income margin2

     

    14.1

    %

     

     

    11.3

    %

    __________

    1.

    The Company defines Adjusted Net Income as net income adjusted for other expense, net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses, as applicable, adjusted to give effect to the income tax impact of such adjustments. The Company believes that the presentation of Adjusted Net Income provides additional information to investors about certain non-cash items and unusual items that are not expected to continue at the same level in the future. Further, the Company believes Adjusted Net Income provides a meaningful measure of business performance. There are material limitations to using Adjusted Net Income. Adjusted Net Income does not take into account certain significant items, including other expense, net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's net income, as applicable. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Adjusted Net Income in conjunction with net income as calculated in accordance with GAAP.

     

    2.

    Adjusted Net Income margin is calculated as Adjusted Net Income as a percentage of revenue.

     

    3.

    The Company computed the tax effect of adjustments to net earnings by applying the statutory tax rate in the relevant jurisdictions to the taxable income or expense items that are adjusted in the period presented. If a valuation allowance exists, the rate applied is zero.

    The table below reconciles diluted earnings per share to Adjusted Diluted Earnings Per Share.

     

    Three Months Ended March 31,

     

     

    2026

     

     

     

    2025

     

    Diluted earnings per share

    $

    0.45

     

     

    $

    0.33

     

    Other expense, net

     

    0.01

     

     

     

    0.02

     

    Stock-based compensation

     

    0.06

     

     

     

    0.04

     

    Restructuring

     

    —

     

     

     

    (0.01

    )

    Tax effect of adjustments2

     

    (0.02

    )

     

     

    (0.01

    )

    Adjusted Diluted Earnings Per Share1

    $

    0.50

     

     

    $

    0.37

     

     

    __________

    1.

    The Company defines Adjusted Diluted Earnings Per Share as diluted earnings per share attributable to stockholders of UL Solutions adjusted for other expense, net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses, as applicable, adjusted to give effect to the income tax impact of such adjustments. The Company believes that the presentation of Adjusted Diluted Earnings Per Share provides additional information to investors about certain non-cash items and unusual items that are not expected to continue at the same level in the future. Further, the Company believes Adjusted Diluted Earnings Per Share provides a meaningful measure of business performance. There are material limitations to using Adjusted Diluted Earnings Per Share. Adjusted Diluted Earnings Per Share does not take into account certain significant items, including other expense, net, stock-based compensation expense for equity-settled awards, material asset impairment charges and restructuring expenses which directly affect the Company's diluted earnings per share, as applicable. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Adjusted Diluted Earnings Per Share in conjunction with diluted earnings per share as calculated in accordance with GAAP.

     

    2.

    See definition on previous page.

    The table below reconciles net cash provided by operating activities to Free Cash Flow.

     

    Three Months Ended March 31,

    (in millions)

     

    2026

     

     

     

    2025

     

    Net cash provided by operating activities

    $

    219

     

     

    $

    154

     

    Capital expenditures

     

    (69

    )

     

     

    (51

    )

    Free Cash Flow1

    $

    150

     

     

    $

    103

     

    Revenue

    $

    758

     

     

    $

    705

     

    Net cash provided by operating activities margin

     

    28.9

    %

     

     

    21.8

    %

    Free Cash Flow margin2

     

    19.8

    %

     

     

    14.6

    %

     

    __________

    1.

    The Company defines Free Cash Flow as cash from operating activities less cash outlays related to capital expenditures. The Company defines capital expenditures to include purchases of property, plant and equipment and capitalized software. These items are subtracted from cash from operating activities because they represent long-term investments that are required for normal business activities. The Company uses Free Cash Flow as an additional liquidity measure and believes it provides useful information to investors about the cash generated from its core operations that may be available to repay debt, make other investments and return cash to stockholders. There are material limitations to using Free Cash Flow. Free Cash Flow adjusts for cash items that are ultimately within management's discretion to direct, and therefore, may imply that there is less or more cash that is available than the most comparable GAAP measure. Free Cash Flow is not intended to represent residual cash flow for discretionary expenditures since debt repayment requirements and other non-discretionary expenditures are not deducted. These limitations are best addressed by considering the economic effects of the excluded items independently, and by considering Free Cash Flow in conjunction with net cash provided by operating activities as calculated in accordance with GAAP.

     

    2.

    Free Cash Flow margin is calculated as Free Cash Flow as a percentage of revenue.

    Selected Financial Information Reflecting the Company's Segment Reorganization for Certain Historical Periods

    Effective beginning in the first quarter of 2026, the Company reorganized its segments to be consistent with how the Chief Executive Officer currently evaluates business performance and allocates resources. The changes primarily related to the Company's Advisory business, which was previously included within the Software and Advisory segment and is now included within the Industrial segment. As a result of the reorganization, the Software and Advisory segment was renamed "Risk & Compliance Software" and costs related to the Company's corporate functions were reallocated across its segments. This reorganization had no impact on the Company's consolidated financial position, results of operations or cash flows.

    The following table reconciles historical segment operating income to segment Adjusted EBITDA, both of which have been recast to reflect the Company's segment reorganization:

     

    Three

    Months

    Ended

    March 31,

     

    Three

    Months

    Ended

    June 30,

     

    Three

    Months

    Ended

    September 30,

     

    Three

    Months

    Ended

    December 31,

     

    Year Ended

    December 31,

    (in millions, unless otherwise stated)

     

    2025

     

     

     

    2025

     

     

     

    2025

     

     

     

    2025

     

     

     

    2025

     

     

     

    2024

     

    Industrial

     

     

     

     

     

     

     

     

     

     

     

    Segment operating income

    $

    83

     

     

    $

    100

     

     

    $

    109

     

     

    $

    104

     

     

    $

    396

     

     

    $

    349

     

    Depreciation and amortization expense

     

    16

     

     

     

    16

     

     

     

    15

     

     

     

    17

     

     

     

    64

     

     

     

    54

     

    Stock-based compensation

     

    3

     

     

     

    5

     

     

     

    7

     

     

     

    5

     

     

     

    20

     

     

     

    10

     

    Restructuring

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    7

     

     

     

    7

     

     

     

    —

     

    Adjusted EBITDA1

    $

    102

     

     

    $

    121

     

     

    $

    131

     

     

    $

    133

     

     

    $

    487

     

     

    $

    413

     

    Revenue

    $

    340

     

     

    $

    373

     

     

    $

    379

     

     

    $

    388

     

     

    $

    1,480

     

     

    $

    1,377

     

    Operating income margin

     

    24.4

    %

     

     

    26.8

    %

     

     

    28.8

    %

     

     

    26.8

    %

     

     

    26.8

    %

     

     

    25.3

    %

    Adjusted EBITDA margin2

     

    30.0

    %

     

     

    32.4

    %

     

     

    34.6

    %

     

     

    34.3

    %

     

     

    32.9

    %

     

     

    30.0

    %

     

     

     

     

     

     

     

     

     

     

     

     

    Consumer

     

     

     

     

     

     

     

     

     

     

     

    Segment operating income

    $

    22

     

     

    $

    37

     

     

    $

    40

     

     

    $

    9

     

     

    $

    108

     

     

    $

    98

     

    Depreciation and amortization expense

     

    19

     

     

     

    20

     

     

     

    20

     

     

     

    23

     

     

     

    82

     

     

     

    80

     

    Stock-based compensation

     

    4

     

     

     

    6

     

     

     

    7

     

     

     

    4

     

     

     

    21

     

     

     

    11

     

    Restructuring

     

    (1

    )

     

     

    (1

    )

     

     

    —

     

     

     

    28

     

     

     

    26

     

     

     

    (1

    )

    Adjusted EBITDA1

    $

    44

     

     

    $

    62

     

     

    $

    67

     

     

    $

    64

     

     

    $

    237

     

     

    $

    188

     

    Revenue

    $

    304

     

     

    $

    340

     

     

    $

    340

     

     

    $

    335

     

     

    $

    1,319

     

     

    $

    1,254

     

    Operating income margin

     

    7.2

    %

     

     

    10.9

    %

     

     

    11.8

    %

     

     

    2.7

    %

     

     

    8.2

    %

     

     

    7.8

    %

    Adjusted EBITDA margin2

     

    14.5

    %

     

     

    18.2

    %

     

     

    19.7

    %

     

     

    19.1

    %

     

     

    18.0

    %

     

     

    15.0

    %

     

     

     

     

     

     

     

     

     

     

     

     

    Risk & Compliance Software

     

     

     

     

     

     

     

     

     

     

     

    Segment operating income

    $

    4

     

     

    $

    2

     

     

    $

    7

     

     

    $

    5

     

     

    $

    18

     

     

    $

    15

     

    Depreciation and amortization expense

     

    10

     

     

     

    10

     

     

     

    11

     

     

     

    11

     

     

     

    42

     

     

     

    38

     

    Stock-based compensation

     

    1

     

     

     

    2

     

     

     

    1

     

     

     

    2

     

     

     

    6

     

     

     

    2

     

    Restructuring

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    2

     

     

     

    2

     

     

     

    —

     

    Adjusted EBITDA1

    $

    15

     

     

    $

    14

     

     

    $

    19

     

     

    $

    20

     

     

    $

    68

     

     

    $

    55

     

    Revenue

    $

    61

     

     

    $

    63

     

     

    $

    64

     

     

    $

    66

     

     

    $

    254

     

     

    $

    239

     

    Operating income margin

     

    6.6

    %

     

     

    3.2

    %

     

     

    10.9

    %

     

     

    7.6

    %

     

     

    7.1

    %

     

     

    6.3

    %

    Adjusted EBITDA margin2

     

    24.6

    %

     

     

    22.2

    %

     

     

    29.7

    %

     

     

    30.3

    %

     

     

    26.8

    %

     

     

    23.0

    %

     

    __________

    1.

    As previously defined.

    2.

    As previously defined.

    Source code: ULS-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260505981610/en/

    Media:

    Kathy Fieweger

    Senior Vice President and Chief Corporate Communications Officer

    Kathy.Fieweger@ul.com

    +1 312-852-5156

    Investors:

    Yijing Brentano

    Vice President, Investor Relations

    IR@ul.com

    +1 312-895-9873

    Get the next $ULS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    2/17/2026$86.00Buy
    BofA Securities
    12/17/2025$97.00Neutral → Outperform
    Robert W. Baird
    11/5/2025$84.00Overweight → Neutral
    Analyst
    5/14/2025$71.00Buy → Neutral
    Citigroup
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    SEC Filings

    View All

    UL Solutions Inc. filed SEC Form 8-K: Leadership Update

    8-K - UL Solutions Inc. (0001901440) (Filer)

    6/3/26 4:13:28 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - UL Solutions Inc. (0001901440) (Filer)

    5/22/26 12:57:21 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.

    SCHEDULE 13G/A - UL Solutions Inc. (0001901440) (Subject)

    5/14/26 12:52:52 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UL Solutions to Attend Upcoming Investor Conferences

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that senior management of the company will attend the following investor conferences: William Blair 46th Annual Growth Stock Conference, June 2 Stifel 2026 Boston Cross Sector 1x1 Conference, June 3 Baird 2026 Global Consumer, Technology & Services Conference, June 4 The company's presentation at the William Blair 46th Annual Growth Stock Conference on June 2 will be broadcast live at 8 a.m. CDT. The webcast can be accessed through the UL Solutions Investor Relations website at ir.ul.com. A replay of the webcast will be available on the website for 30 days after the event. Presentation mat

    6/1/26 8:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.145 per share. The dividend will be paid on June 8 to shareholders of record as of the close of business on May 29. About UL Solutions A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, advisory offerings and software solutions that support our customers' product innovation and business growth. The UL Mark serves as a recogn

    5/20/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Warns of Unauthorized UL Marks on Electric Scooters

    Unauthorized certification marks were applied to certain electric scooters, which have not been evaluated by UL Solutions to the appropriate safety standards, posing potential risks to consumers. UL Solutions (NYSE:ULS), a global leader in applied safety science, issued a public notice regarding electric scooters, product models AS-STR280, GT08, M1, M2 Plus, M3 Max, M6 Pro and Z2, which bear unauthorized UL certification marks and may pose safety risks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260515696194/en/UL Solutions issued a public notice regarding electric scooters, product models AS-STR280, GT08, M1, M2 Plus, M3

    5/15/26 8:30:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Scanlon Jennifer F. sold $1,249,983 worth of shares (12,500 units at $100.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 176,724 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    6/3/26 4:15:33 PM ET
    $ULS
    Precision Instruments
    Health Care

    Executive VP & CFO Robinson Ryan D gifted 29,268 shares and received a gift of 29,268 shares, decreasing direct ownership by 96% to 1,290 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    6/2/26 4:17:47 PM ET
    $ULS
    Precision Instruments
    Health Care

    EVP & CCO Uggetti Alberto sold $234,242 worth of shares (2,345 units at $99.89) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 7,962 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    6/1/26 4:05:52 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on UL Solutions Inc. with a new price target

    BofA Securities resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $86.00

    2/17/26 7:29:05 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded UL Solutions Inc. from Neutral to Outperform and set a new price target of $97.00

    12/17/25 8:48:07 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. downgraded by Analyst with a new price target

    Analyst downgraded UL Solutions Inc. from Overweight to Neutral and set a new price target of $84.00

    11/5/25 7:29:40 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Genovesi John A bought $9,366 worth of shares (145 units at $64.59), increasing direct ownership by 0.57% to 31,112 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    5/15/26 4:48:07 PM ET
    $ULS
    Precision Instruments
    Health Care

    Officer Hancock Lynn H bought $623 worth of shares (8 units at $77.82), converted options into 1,293 shares and covered exercise/tax liability with 573 shares, increasing direct ownership by 4% to 21,331 units (SEC Form 4)

    4 - UL Solutions Inc. (0001901440) (Issuer)

    5/5/26 5:51:09 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Financials

    Live finance-specific insights

    View All

    UL Solutions Announces Quarterly Dividend

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that its board of directors has declared a quarterly dividend of $0.145 per share. The dividend will be paid on June 8 to shareholders of record as of the close of business on May 29. About UL Solutions A global leader in applied safety science, UL Solutions Inc. (NYSE:ULS) transforms safety, security and sustainability challenges into opportunities for customers in more than 110 countries. UL Solutions delivers testing, inspection and certification services, advisory offerings and software solutions that support our customers' product innovation and business growth. The UL Mark serves as a recogn

    5/20/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Reports Strong First Quarter 2026 Results

    First Quarter 20261 Strong revenue growth of 7.5% to $758 million, including 5.7% organic revenue growth Net income of $97 million increased 36.6%, Adjusted Net Income of $107 million increased 33.8%. Net income margin of 12.8% increased 270 basis points Diluted earnings per share of $0.45 increased 36.4%, Adjusted Diluted Earnings Per Share of $0.50 increased 35.1% Adjusted EBITDA of $197 million increased 22.4%, Adjusted EBITDA margin of 26.0% expanded 320 basis points Active portfolio management to enhance strategic focus and fund growth Strengthens full-year Adjusted EBITDA margin outlook UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today

    5/5/26 7:00:00 AM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Broadens Portfolio with Agreement to Acquire Eurofins Scientific's Electrical & Electronics Business

    Expands UL Solutions' global laboratory footprint and enhances commitment to TIC services for electrical safety and connected products Transaction expected to close in Q4 2026 subject to regulatory approvals and customary closing conditions UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it has entered into a definitive agreement to acquire the electrical and electronics (E&E) business (inclusive of the MET Labs certification mark) of Eurofins Scientific SE ("Eurofins").1 The transaction expands UL Solutions' global footprint and is intended to enhance its testing, inspection and certification (TIC) business for electrical safety and connected

    4/13/26 4:15:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/13/24 12:26:41 PM ET
    $ULS
    Precision Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

    SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 5:49:12 PM ET
    $ULS
    Precision Instruments
    Health Care

    SEC Form SC 13G filed by UL Solutions Inc.

    SC 13G - UL Solutions Inc. (0001901440) (Subject)

    11/12/24 10:34:15 AM ET
    $ULS
    Precision Instruments
    Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    UL Solutions Breaks Ground on Global Fire Science Center of Excellence in Illinois

    The advanced fire safety testing and R&D facility will be dedicated to identifying, evaluating and mitigating fire risks. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory investments to date, helping to reduce fire risks globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826231103/en/UL Solutions has announced the beginning of construction on its state-of-the-art Global Fire Science Center of Excellence, one of the company's largest laboratory i

    8/26/25 5:30:00 PM ET
    $ULS
    Precision Instruments
    Health Care

    UL Solutions Inc. Names New Chief Legal Officer

    UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

    3/11/25 9:15:00 AM ET
    $ULS
    Precision Instruments
    Health Care